These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 20592275)

  • 1. T cell activation leads to protein kinase C theta-dependent inhibition of TGF-beta signaling.
    Giroux M; Delisle JS; O'Brien A; Hébert MJ; Perreault C
    J Immunol; 2010 Aug; 185(3):1568-76. PubMed ID: 20592275
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The physical association of protein kinase C theta with a lipid raft-associated inhibitor of kappa B factor kinase (IKK) complex plays a role in the activation of the NF-kappa B cascade by TCR and CD28.
    Khoshnan A; Bae D; Tindell CA; Nel AE
    J Immunol; 2000 Dec; 165(12):6933-40. PubMed ID: 11120819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. TRAIL-receptor costimulation inhibits proximal TCR signaling and suppresses human T cell activation and proliferation.
    Lehnert C; Weiswange M; Jeremias I; Bayer C; Grunert M; Debatin KM; Strauss G
    J Immunol; 2014 Oct; 193(8):4021-31. PubMed ID: 25217163
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Strength of TCR signal determines the costimulatory requirements for Th1 and Th2 CD4+ T cell differentiation.
    Tao X; Constant S; Jorritsma P; Bottomly K
    J Immunol; 1997 Dec; 159(12):5956-63. PubMed ID: 9550393
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase C-theta-mediated signals enhance CD4+ T cell survival by up-regulating Bcl-xL.
    Manicassamy S; Gupta S; Huang Z; Sun Z
    J Immunol; 2006 Jun; 176(11):6709-16. PubMed ID: 16709830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Smad3 is essential for TGF-beta 1 to suppress IL-2 production and TCR-induced proliferation, but not IL-2-induced proliferation.
    McKarns SC; Schwartz RH; Kaminski NE
    J Immunol; 2004 Apr; 172(7):4275-84. PubMed ID: 15034041
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of protein kinase C theta, Bcl10, or Malt1 selectively impairs proliferation and NF-kappa B activation in the CD4+ T cell subset.
    Kingeter LM; Schaefer BC
    J Immunol; 2008 Nov; 181(9):6244-54. PubMed ID: 18941215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARA and Hgs attenuate susceptibility to TGF-beta1-mediated T cell suppression.
    Kunzmann S; Wohlfahrt JG; Itoh S; Asao H; Komada M; Akdis CA; Blaser K; Schmidt-Weber CB
    FASEB J; 2003 Feb; 17(2):194-202. PubMed ID: 12554698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-CD28-induced co-stimulation and TCR avidity regulates the differential effect of TGF-beta1 on CD4+ and CD8+ naïve human T-cells.
    Gunnlaugsdottir B; Maggadottir SM; Ludviksson BR
    Int Immunol; 2005 Jan; 17(1):35-44. PubMed ID: 15557315
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TCR activation inhibits chemotaxis toward stromal cell-derived factor-1: evidence for reciprocal regulation between CXCR4 and the TCR.
    Peacock JW; Jirik FR
    J Immunol; 1999 Jan; 162(1):215-23. PubMed ID: 9886389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Distinct effects of TGF-beta 1 on CD4+ and CD8+ T cell survival, division, and IL-2 production: a role for T cell intrinsic Smad3.
    McKarns SC; Schwartz RH
    J Immunol; 2005 Feb; 174(4):2071-83. PubMed ID: 15699137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The TGF-β-Smad3 pathway inhibits CD28-dependent cell growth and proliferation of CD4 T cells.
    Delisle JS; Giroux M; Boucher G; Landry JR; Hardy MP; Lemieux S; Jones RG; Wilhelm BT; Perreault C
    Genes Immun; 2013 Mar; 14(2):115-26. PubMed ID: 23328844
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibody-induced CD3-CD4 coligation inhibits TCR/CD3 activation in the absence of costimulatory signals in normal mouse CD4(+) T lymphocytes.
    Portolés P; de Ojeda G; Criado G; Fernández-Centeno E; Rojo JM
    Cell Immunol; 1999 Aug; 195(2):96-109. PubMed ID: 10448009
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T Cell Receptor-Regulated TGF-β Type I Receptor Expression Determines T Cell Quiescence and Activation.
    Tu E; Chia CPZ; Chen W; Zhang D; Park SA; Jin W; Wang D; Alegre ML; Zhang YE; Sun L; Chen W
    Immunity; 2018 Apr; 48(4):745-759.e6. PubMed ID: 29669252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A model for antigen-specific T-cell anergy: displacement of CD4-p56(lck) signalosome from the lipid rafts by a soluble, dimeric peptide-MHC class II chimera.
    Thomas S; Kumar R; Preda-Pais A; Casares S; Brumeanu TD
    J Immunol; 2003 Jun; 170(12):5981-92. PubMed ID: 12794125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD28 co-stimulation regulates the effect of transforming growth factor-beta1 on the proliferation of naïve CD4+ T cells.
    Sung JL; Lin JT; Gorham JD
    Int Immunopharmacol; 2003 Feb; 3(2):233-45. PubMed ID: 12586604
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protein kinase C (PKC) alpha and PKC theta are the major PKC isotypes involved in TCR down-regulation.
    von Essen M; Nielsen MW; Bonefeld CM; Boding L; Larsen JM; Leitges M; Baier G; Odum N; Geisler C
    J Immunol; 2006 Jun; 176(12):7502-10. PubMed ID: 16751397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal lipid rafts related ganglioside expression and signaling in T lymphocytes in immune thrombocytopenia patients.
    Zhang X; Zhang D; Liu W; Li H; Fu R; Liu X; Xue F; Yang R
    Autoimmunity; 2016; 49(1):58-68. PubMed ID: 26287565
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor β (TGF-β) receptor signaling regulates kinase networks and phosphatidylinositol metabolism during T-cell activation.
    Cattley RT; Lee M; Boggess WC; Hawse WF
    J Biol Chem; 2020 Jun; 295(24):8236-8251. PubMed ID: 32358062
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p38 mitogen-activated protein kinase mediates signal integration of TCR/CD28 costimulation in primary murine T cells.
    Zhang J; Salojin KV; Gao JX; Cameron MJ; Bergerot I; Delovitch TL
    J Immunol; 1999 Apr; 162(7):3819-29. PubMed ID: 10201899
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.